Page 996 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 996

982     SECTION VIII  Chemotherapeutic Drugs



                                    A
                                                      Bacteria

                             Epitope





                                                         Antigen-
                                                         binding   Hinge
                                                          region   region
                                                                         C 1 V H
                                         Complementarity-                 H
                                             determining
                                            region (CDR)
                                                             –S-S–  –S-S–  –S-S–     V L
                                                                  –S-S–
                                                                             C H 2  C L
                                                     Fc region
                                                                             C H 3
                                                                                        B

                           C

                           Fc receptor                  Opsonization




                                                                                                   Complement
                                                                                                   activation
                                     Macrophage








                                                                                            Bacterial lysis

                 FIGURE 55–4  Antibody has multiple functions. The prototypical antibody consists of two heavy (H) and two light (L) chains, each subdivided
                 into constant (C L , C H ) and variable (V L , V H ) domains. The structure is held together by intra- and interchain disulfide bridges. A: The complementarity-
                 determining region (CDR) of the antigen-binding portion of the antibody engages the antigenic determinant (epitope) in a lock-and-key fashion.
                 B: Antigen-antibody complexes activate complement to produce split complement components that cause bacterial lysis. C: The Fc portion of anti-
                 bodies binds to Fc receptors on phagocytes (eg, macrophages, neutrophils) and facilitates uptake of bacteria (opsonization).


                 1. Type I—Immediate, or type I, hypersensitivity is IgE-mediated,   IgG immunoglobulins. One example of this type of hypersensitiv-
                 with  symptoms  usually  occurring  within  minutes  following  the   ity is a blood transfusion reaction that can occur if blood is not
                 patient’s reencounter with antigen.  Type I hypersensitivity results   cross-matched properly. Preformed antibodies bind to red blood
                 from cross-linking of membrane-bound IgE on blood basophils   cell membrane antigens that activate the complement cascade,
                 or tissue mast cells by antigen.  This cross-linking causes cells to   generating a membrane attack complex that lyses the transfused
                 degranulate, releasing substances such as histamine, leukotrienes, and   red blood cells. In hemolytic disease of the newborn, anti-Rh
                 eosinophil chemotactic factor, which induce anaphylaxis, asthma,   IgG antibodies produced by an Rh-negative mother cross the pla-
                 hay fever, or urticaria (hives) in affected individuals (Figure 55–5).   centa, bind to red blood cells of an Rh-positive fetus, and damage
                 A severe type I hypersensitivity reaction such as systemic anaphylaxis   them. The disease is prevented in subsequent pregnancies by the
                 (eg, from insect envenomation, ingestion of certain foods, or drug   administration of anti-Rh antibodies to the mother 24–48 hours
                 hypersensitivity) requires immediate medical intervention.  after delivery (see Immunosuppressive Antibodies, below). Type II
                                                                     hypersensitivity can also be drug-induced and may occur during
                 2. Type II—Type II hypersensitivity results from the formation of   the administration of penicillin (for example) to allergic patients.
                 antigen-antibody complexes between foreign antigen and IgM or   In these patients, penicillin binds to red blood cells or other host
   991   992   993   994   995   996   997   998   999   1000   1001